Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie Inc.    ABBV

ABBVIE INC.

(ABBV)
  Report
Delayed Quote. Delayed Nyse - 02/25 04:03:37 pm
89.18 USD   -4.25%
02/25ABBVIE : Form 8.3 -
DJ
02/24ABBVIE : Form 8.3 -
DJ
02/24ABBVIE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

AbbVie : Form 8.3 - -2-

share with twitter share with LinkedIn share with facebook
share via e-mail
01/16/2020 | 09:02am EST
If a connected EFM, name of offeree/offeror with which   N/A 
 connected 
-------------------------------------------------------  ------------------- 
If a connected EFM, state nature of connection (Note     N/A 
 10) 
-------------------------------------------------------  ------------------- 
 
 
 
 
 
 

This article is part of a news chaine.
Article 2 / 2
<< Preceding Next >>
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ABBVIE INC.
02/25ABBVIE : Form 8.3 -
DJ
02/24ABBVIE : Form 8.3 -
DJ
02/24ABBVIE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02/24ABBVIE : Announces Extension of Expiration Date for Exchange Offers for Allergan..
PR
02/21ABBVIE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
02/21ABBVIE : Form 8.3 -
DJ
02/20ABBVIE : Declares Quarterly Dividend
PR
02/20ABBVIE : Form 8.3 - Abbvie Inc.
DJ
02/19ABBVIE : Form 8.3 - Abbvie Inc
DJ
02/19ABBVIE : to Present at the Cowen 40th Annual Health Care Conference
PR
More news
Financials (USD)
Sales 2020 35 984 M
EBIT 2020 17 356 M
Net income 2020 10 791 M
Debt 2020 24 609 M
Yield 2020 5,37%
P/E ratio 2020 9,86x
P/E ratio 2021 9,07x
EV / Sales2020 4,35x
EV / Sales2021 3,90x
Capitalization 132 B
Chart ABBVIE INC.
Duration : Period :
AbbVie Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBVIE INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 101,00  $
Last Close Price 89,18  $
Spread / Highest target 45,8%
Spread / Average Target 13,3%
Spread / Lowest Target -5,81%
EPS Revisions
Managers
NameTitle
Richard A. Gonzalez Chairman & Chief Executive Officer
Michael E. Severino Vice Chairman & President
Azita Saleki-Gerhardt Executive Vice President-Operations
Robert A. Michael Chief Financial Officer & Senior Vice President
Carlos Alban Vice Chairman & Chief Commercial Officer
Sector and Competitors
1st jan.Capitalization (M$)
ABBVIE INC.0.72%131 911
JOHNSON & JOHNSON0.03%381 112
ROCHE HOLDING AG10.13%287 430
MERCK AND COMPANY-11.74%204 366
NOVARTIS2.72%201 414
PFIZER-11.51%187 773